Nutritional Rehabilitation in Patients with Malnutrition Due to Crohn's Disease.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
04 Dec 2019
Historique:
received: 16 09 2019
revised: 15 11 2019
accepted: 21 11 2019
entrez: 11 12 2019
pubmed: 11 12 2019
medline: 7 7 2020
Statut: epublish

Résumé

Crohn's disease (CD) is a chronic inflammatory bowel disease frequently associated with malabsorption and secondary protein-energy malnutrition (PEM). Biochemical and clinical data of 63 (34 females, 29 males) patients with PEM due to CD sent to our outpatient unit for nutritional evaluation were retrospectively analyzed. Patients were divided into two groups, according to disease activity. Thirty-eight patients (group A) had the active disease, and 25 patients (group B) suffered from malabsorption resulting from past intestinal resections due to CD. After a physical and hemato-biochemical evaluation at the first visit, all patients received disease-specific personalized dietetic indications. When indicated, oral nutritional supplements, oral/parenteral vitamins, micronutrients, and electrolytes, up to parenteral nutrition, were prescribed. After 1, 3, and 6 months of nutritional therapy, body weight, body mass index (BMI), and serum butyryl-cholinesterase significantly improved in both groups. In 8 out of 13 (61.5%) patients with a cutaneous stoma, intestinal continuity was restored. This study confirms the effectiveness of nutritional rehabilitation and provides information on the time required for nutritional treatment in patients with CD, both during the acute phase and after malabsorption due to intestinal resection.

Sections du résumé

BACKGROUND BACKGROUND
Crohn's disease (CD) is a chronic inflammatory bowel disease frequently associated with malabsorption and secondary protein-energy malnutrition (PEM).
METHODS METHODS
Biochemical and clinical data of 63 (34 females, 29 males) patients with PEM due to CD sent to our outpatient unit for nutritional evaluation were retrospectively analyzed. Patients were divided into two groups, according to disease activity. Thirty-eight patients (group A) had the active disease, and 25 patients (group B) suffered from malabsorption resulting from past intestinal resections due to CD. After a physical and hemato-biochemical evaluation at the first visit, all patients received disease-specific personalized dietetic indications. When indicated, oral nutritional supplements, oral/parenteral vitamins, micronutrients, and electrolytes, up to parenteral nutrition, were prescribed.
RESULTS RESULTS
After 1, 3, and 6 months of nutritional therapy, body weight, body mass index (BMI), and serum butyryl-cholinesterase significantly improved in both groups. In 8 out of 13 (61.5%) patients with a cutaneous stoma, intestinal continuity was restored.
CONCLUSIONS CONCLUSIONS
This study confirms the effectiveness of nutritional rehabilitation and provides information on the time required for nutritional treatment in patients with CD, both during the acute phase and after malabsorption due to intestinal resection.

Identifiants

pubmed: 31817074
pii: nu11122947
doi: 10.3390/nu11122947
pmc: PMC6950059
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

J Cachexia Sarcopenia Muscle. 2013 Mar;4(1):31-9
pubmed: 22956442
Clin Nutr. 2017 Apr;36(2):321-347
pubmed: 28131521
Clin Nutr. 2019 Jul 4;:null
pubmed: 31303525
Gut. 2006 Mar;55 Suppl 1:i16-35
pubmed: 16481629
Inflamm Bowel Dis. 2011 Jan;17(1):471-8
pubmed: 20725943
Nutrients. 2018 Apr 26;10(5):null
pubmed: 29701656
Gut. 2006 Aug;55 Suppl 4:iv1-12
pubmed: 16837533
Lancet. 2007 May 12;369(9573):1641-57
pubmed: 17499606
Lancet. 2006 Apr 1;367(9516):1101-1111
pubmed: 16581410
Proc Nutr Soc. 2011 Aug;70(3):336-41
pubmed: 21669026
Eur J Clin Nutr. 2000 Jun;54(6):514-21
pubmed: 10878655
Expert Opin Pharmacother. 2002 Jul;3(7):809-25
pubmed: 12083982
Best Pract Res Clin Gastroenterol. 2004 Oct;18(5):977-92
pubmed: 15494290
J Clin Gastroenterol. 2006 May-Jun;40 Suppl 2:S94-8
pubmed: 16770168
World J Gastroenterol. 2006 Jun 7;12(21):3380-5
pubmed: 16733855
World J Gastroenterol. 2009 May 7;15(17):2081-8
pubmed: 19418580

Auteurs

Lidia Santarpia (L)

Internal Medicine and Clinical Nutrition Unit, Department of Clinical Medicine and Surgery, Federico II University Hospital of Naples, Via Pansini, 5, 80131 Naples, Italy.

Lucia Alfonsi (L)

Internal Medicine and Clinical Nutrition Unit, Department of Clinical Medicine and Surgery, Federico II University Hospital of Naples, Via Pansini, 5, 80131 Naples, Italy.

Fabiana Castiglione (F)

Gastroenterology Unit, Department of Clinical Medicine and Surgery, Federico II University Hospital of Naples, Via Pansini, 5, 80131 Naples, Italy.

Maria Carmen Pagano (MC)

Internal Medicine and Clinical Nutrition Unit, Department of Clinical Medicine and Surgery, Federico II University Hospital of Naples, Via Pansini, 5, 80131 Naples, Italy.

Iolanda Cioffi (I)

Internal Medicine and Clinical Nutrition Unit, Department of Clinical Medicine and Surgery, Federico II University Hospital of Naples, Via Pansini, 5, 80131 Naples, Italy.

Antonio Rispo (A)

Gastroenterology Unit, Department of Clinical Medicine and Surgery, Federico II University Hospital of Naples, Via Pansini, 5, 80131 Naples, Italy.

Maurizio Sodo (M)

General and Transplantation Surgery, Department of Public Health, Federico II University Hospital, 80131 Naples, Italy.

Franco Contaldo (F)

Internal Medicine and Clinical Nutrition Unit, Department of Clinical Medicine and Surgery, Federico II University Hospital of Naples, Via Pansini, 5, 80131 Naples, Italy.

Fabrizio Pasanisi (F)

Internal Medicine and Clinical Nutrition Unit, Department of Clinical Medicine and Surgery, Federico II University Hospital of Naples, Via Pansini, 5, 80131 Naples, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH